BPC-157 (Body Protection Compound-157) upregulates vascular endothelial growth factor (VEGF) and drives angiogenesis, the construction of new blood vessels at the injury site
the present invention also relates to a pharmaceutical or diagnostic composition according to the above, which in addition to one or more of the BPC peptide salts of the present invention, contains trehalose, in particular for peroral use, and/or pharmaceutically or diagnostically acceptable carriers, dilutents and/or additives
Really has helped build my immune system back after COVID
However, 3mL is popular among experienced researchers because the 3.33mg/mL concentration provides a good balance between dose precision and total injectable volume
Ng F, Berk M, Dean O, Bush AI